Cyfuse Biomedical K.K.
Research Cyfuse Biomedical K.K. (4892.T) on Bullrun: market cap JPY 6.15B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4892.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 6.15B
- Financial periodFY2025
- RevenueJPY 231.00M
- Revenue growth324.3%
- Net income-JPY 763.84M
- Free cash flow-JPY 582.36M
- Gross margin49.3%
Valuation Snapshot
latest market cap is JPY 6.15B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 231.00M | -JPY 763.84M | -JPY 582.36M | 49.3% | -86.78 | JPY 3.73B | JPY 1.31B | JPY 2.76B |
| FY2024 | JPY 54.45M | -JPY 872.24M | -JPY 769.10M | 30.9% | -108.34 | JPY 3.05B | JPY 852.80M | JPY 2.54B |
| FY2023 | JPY 61.11M | -JPY 589.21M | -JPY 581.77M | 61.8% | -75.42 | JPY 3.87B | JPY 913.00M | JPY 3.20B |
| FY2022 | JPY 374.48M | -JPY 473.96M | -JPY 631.87M | 64.5% | -177.67 | JPY 4.44B | JPY 908.14M | JPY 3.77B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 6.15B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cyfuse Biomedical K.K.'s market cap?
Cyfuse Biomedical K.K.'s market capitalization is JPY 6.15B.
What does Cyfuse Biomedical K.K. do?
Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells. It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of drugs. Cyfuse Biomedical K.K.